|
About Nanogen, Inc.
Nanogen has developed a strong product and proprietary technology base in
advanced diagnostic solutions for two of the fastest growing in vitro diagnostic
(IVD) markets – molecular diagnostics and rapid point-of-care testing. The role
of diagnostics in healthcare is evolving rapidly buoyed by new and improved
technologies that allow the advancement and decentralization of diagnostic
applications. Products like those from Nanogen are quickening the pace toward
personalized medicine. Both clinical laboratories and point-of-care providers
are seeing strong validation of the contribution advanced diagnostic tests can
have for the delivery of better, more personalized patient care. With its
growing diagnostics product offering, Nanogen is poised to become a key player
in this arena.
Nanogen’s products are used in multiple segments of the global IVD market -
including applications in which testing is used as a prognostic indicator of
disease and for ongoing monitoring of disease. Products include a broad menu of
real-time PCR reagents and kits for DNA and RNA infectious disease targets as
well as genotyping assays for key biomarkers in onco-hematology. The Company’s
rapid tests for acute cardiac conditions and drugs of abuse are sold to
customers requiring rapid results at or near the point of treatment such as
emergency rooms.
All of Nanogen’s products are designed to improve the role diagnostics plays
in improving individual patient care by providing more specific DNA-based
results or by moving the diagnostic capability and decision closer to the
patient. The strong intellectual property portfolio of advanced diagnostic
technologies allows the company to bring unique solutions to the market. The IP
portfolio includes: the MGB Eclipse® probes technology which is widely licensed
and has proven to be a mainstay in helping to make real-time PCR a gold standard
method in molecular biology research and diagnostic testing; and key patents for
the reporting of multiple biomarkers in a rapid test format.
|
